Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04177862 · ClinicalTrials.gov registry record · Phase 4
Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center
A Phase 4 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT04177862 is a Phase 4 study that has completed, run by University of Minnesota. The registered enrollment target is 75 participants.
The verdict
NCT04177862, a Phase 4 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a single dose of sublingual sufentanil is as or more efficacious than a single dose of IV fentanyl in a post anesthesia care setting.
Interventions
- DRUG Sublingual Sufentanil
- DRUG IV Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2019-12-11 |
| Est. Completion | 2020-01-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04177862
The ClinicalTrials.gov registry entry for NCT04177862 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sublingual Sufentanil is the first listed.
NCT04177862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04177862 about?
NCT04177862 is a clinical study titled "Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center". The purpose of this study is to determine if a single dose of sublingual sufentanil is as or more efficacious than a single dose of IV fentanyl in a post anesthesia care setting.
What is the current status of trial NCT04177862?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2019-12-11. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT04177862?
The interventions under investigation include: Sublingual Sufentanil (DRUG), IV Fentanyl (DRUG).
Who is sponsoring clinical trial NCT04177862?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.